Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Main human AOD-9604 treatment timelines Study METAOD004 Participants 36 Route Oral Treatment length 7 days Dose range 9, 27, or 54 mg/day Main lesson Short safety and tolerability study Study METAOD005 Participants 300 Route Oral Treatment length 12 weeks Dose range 1 to 30 mg/day Main lesson Earlier weight-loss trial with a non-linear dose response Study METAOD006 Participants 502 randomized Route Oral Treatment length 24 weeks Dose range 0.25, 0.5, or 1 mg/day Main lesson Primary weight-loss goal was not met The oral milligram doses in these trials cannot be converted into subcutaneous microgram doses
Intramuscular and intravenous delivery bypasses the gastrointestinal tract, achieving significantly higher bioavailability than oral supplementation, making injectable micronutrients a clinically effective option for patients with confirmed or suspected deficiency, malabsorption conditions, or chronic illness
How many shots do you need
More research is needed to understand whether AOD-9604 has any meaningful effect on how the body uses energy
This makes it easier to stay organized and ensure that you have the peptides you need for your ongoing research
Cleveland Clinics classical hematology experts provide personalized care and support.
